News
Researchers at Massachusetts Institute of Technology (MIT) have developed a way to 'supercharge' vaccines to the extent that ...
The approach employed by the research team could be used against other diseases—including COVID-19 and influenza.
Researchers from MIT and Scripps have unveiled a promising new HIV vaccine approach that generates a powerful immune response ...
MIT and Scripps scientists explore a single-dose vaccine approach by combining two immune-boosting ingredients.
Immuno Cure BioTech and PharmaJet are working together on a clinical study to test the effectiveness of PharmaJet’s ...
Kennedy testified before the House Energy and Commerce Health Subcommittee about health spending cuts and health agency ...
Groundbreaking single-dose vaccine found effective in preventing HIV - Strategy may lead to new vaccines that only need to be ...
Clinical trials showed 99.9% of participants who received the drug, called Yeztugo from company Gilead Sciences, remained ...
The Trump administration's plan to cut funding for HIV vaccine research comes at a time when the field is making substantial ...
WASHINGTON — The U.S. has approved the world’s only twice-a-year shot to prevent HIV, the first step in an anticipated global ...
4d
Asianet Newsable on MSNGroundbreaking HIV supercharged vaccine could protect well with just one doseResearchers from MIT and Scripps have unveiled a promising new HIV vaccine approach that generates a powerful immune response ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results